Search

Jennifer Sue Pitrak Mcdonald

Examiner (ID: 18643, Phone: (571)270-3061 , Office: P/1674 )

Most Active Art Unit
1635
Art Unit(s)
1609, 3796, 3792, 1635, 1674
Total Applications
600
Issued Applications
220
Pending Applications
26
Abandoned Applications
355

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5777337 [patent_doc_number] => 20060105977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Desmoglein 4 is a novel gene involved in hair growth' [patent_app_type] => utility [patent_app_number] => 11/251340 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 25231 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105977.pdf [firstpage_image] =>[orig_patent_app_number] => 11251340 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/251340
Desmoglein 4 is a novel gene involved in hair growth Oct 13, 2005 Abandoned
Array ( [id] => 5638052 [patent_doc_number] => 20060069026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Treatment of obesity' [patent_app_type] => utility [patent_app_number] => 11/235232 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6266 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069026.pdf [firstpage_image] =>[orig_patent_app_number] => 11235232 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/235232
Treatment of obesity Sep 26, 2005 Abandoned
Array ( [id] => 5029132 [patent_doc_number] => 20070270579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 11/234730 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 93035 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270579.pdf [firstpage_image] =>[orig_patent_app_number] => 11234730 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/234730
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) Sep 22, 2005 Abandoned
Array ( [id] => 5720730 [patent_doc_number] => 20060073505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Oligomeric compounds effecting drosha-mediated cleavage' [patent_app_type] => utility [patent_app_number] => 11/230992 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29993 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073505.pdf [firstpage_image] =>[orig_patent_app_number] => 11230992 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/230992
Oligomeric compounds effecting drosha-mediated cleavage Sep 19, 2005 Abandoned
Array ( [id] => 5210964 [patent_doc_number] => 20070249548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Nucleoside Analog or Salts of the Same' [patent_app_type] => utility [patent_app_number] => 11/663086 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15964 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249548.pdf [firstpage_image] =>[orig_patent_app_number] => 11663086 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663086
Nucleoside Analog or Salts of the Same Sep 15, 2005 Abandoned
Array ( [id] => 4753181 [patent_doc_number] => 20080161256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 11/205646 [patent_app_country] => US [patent_app_date] => 2005-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 96250 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161256.pdf [firstpage_image] =>[orig_patent_app_number] => 11205646 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/205646
RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) Aug 16, 2005 Abandoned
Array ( [id] => 7251208 [patent_doc_number] => 20050272817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Dermatological use and a dermatological preparation' [patent_app_type] => utility [patent_app_number] => 11/198133 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3017 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272817.pdf [firstpage_image] =>[orig_patent_app_number] => 11198133 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198133
Dermatological use and a dermatological preparation Aug 7, 2005 Abandoned
Array ( [id] => 5720353 [patent_doc_number] => 20060073127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules' [patent_app_type] => utility [patent_app_number] => 11/179792 [patent_app_country] => US [patent_app_date] => 2005-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20944 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 67 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073127.pdf [firstpage_image] =>[orig_patent_app_number] => 11179792 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/179792
Therapeutic alteration of transplantable tissues through in situ or ex vivo exposure to RNA interference molecules Jul 10, 2005 Issued
Array ( [id] => 6931731 [patent_doc_number] => 20050282766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers' [patent_app_type] => utility [patent_app_number] => 11/177138 [patent_app_country] => US [patent_app_date] => 2005-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16134 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282766.pdf [firstpage_image] =>[orig_patent_app_number] => 11177138 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/177138
Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers Jul 7, 2005 Abandoned
Array ( [id] => 5446966 [patent_doc_number] => 20090048192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation' [patent_app_type] => utility [patent_app_number] => 11/569955 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43724 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048192.pdf [firstpage_image] =>[orig_patent_app_number] => 11569955 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/569955
Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation Jun 1, 2005 Abandoned
Array ( [id] => 4899813 [patent_doc_number] => 20080119427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation' [patent_app_type] => utility [patent_app_number] => 11/569931 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 45608 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119427.pdf [firstpage_image] =>[orig_patent_app_number] => 11569931 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/569931
Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation Jun 1, 2005 Abandoned
Array ( [id] => 5808322 [patent_doc_number] => 20060094677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Inhibition of apoptosis-specific eIF-5A (\"eIF-5A1\") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics' [patent_app_type] => utility [patent_app_number] => 11/134445 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 131 [patent_figures_cnt] => 131 [patent_no_of_words] => 35753 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094677.pdf [firstpage_image] =>[orig_patent_app_number] => 11134445 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/134445
Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics May 22, 2005 Abandoned
Array ( [id] => 5808322 [patent_doc_number] => 20060094677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Inhibition of apoptosis-specific eIF-5A (\"eIF-5A1\") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics' [patent_app_type] => utility [patent_app_number] => 11/134445 [patent_app_country] => US [patent_app_date] => 2005-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 131 [patent_figures_cnt] => 131 [patent_no_of_words] => 35753 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094677.pdf [firstpage_image] =>[orig_patent_app_number] => 11134445 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/134445
Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics May 22, 2005 Abandoned
Array ( [id] => 7178892 [patent_doc_number] => 20050204414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells' [patent_app_type] => utility [patent_app_number] => 11/128496 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12087 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20050204414.pdf [firstpage_image] =>[orig_patent_app_number] => 11128496 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/128496
Methods of blocking tissue destruction by autoreactive T cells May 12, 2005 Abandoned
Array ( [id] => 4515401 [patent_doc_number] => 07932234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Bispecific oligonucleotide for the treatment of CNS malignancies' [patent_app_type] => utility [patent_app_number] => 10/908496 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3599 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932234.pdf [firstpage_image] =>[orig_patent_app_number] => 10908496 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/908496
Bispecific oligonucleotide for the treatment of CNS malignancies May 12, 2005 Issued
Array ( [id] => 7178889 [patent_doc_number] => 20050204413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells' [patent_app_type] => utility [patent_app_number] => 11/128495 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12087 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20050204413.pdf [firstpage_image] =>[orig_patent_app_number] => 11128495 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/128495
Methods of blocking tissue destruction by autoreactive T cells May 12, 2005 Abandoned
Array ( [id] => 4976848 [patent_doc_number] => 20070218079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'METHOD TO INDUCE RNAI IN PROKARYOTIC ORGANISMS' [patent_app_type] => utility [patent_app_number] => 11/596176 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5017 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218079.pdf [firstpage_image] =>[orig_patent_app_number] => 11596176 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/596176
METHOD TO INDUCE RNAI IN PROKARYOTIC ORGANISMS May 11, 2005 Abandoned
Array ( [id] => 5733487 [patent_doc_number] => 20060258604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Compositions and methods for the treatment of inflammatory bowel disease utilizing NF-kappaB decoy polynucleotides' [patent_app_type] => utility [patent_app_number] => 11/125919 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20653 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258604.pdf [firstpage_image] =>[orig_patent_app_number] => 11125919 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/125919
Compositions and methods for the treatment of inflammatory bowel disease utilizing NF-kappaB decoy polynucleotides May 9, 2005 Abandoned
Array ( [id] => 4807464 [patent_doc_number] => 20080171042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Cd44 Variants As Therapeutic Targets' [patent_app_type] => utility [patent_app_number] => 11/579785 [patent_app_country] => US [patent_app_date] => 2005-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18074 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171042.pdf [firstpage_image] =>[orig_patent_app_number] => 11579785 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/579785
Cd44 Variants As Therapeutic Targets May 8, 2005 Abandoned
Array ( [id] => 6977840 [patent_doc_number] => 20050287558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'SNPs of apolipoprotein B and modulation of their expression' [patent_app_type] => utility [patent_app_number] => 11/124020 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29340 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287558.pdf [firstpage_image] =>[orig_patent_app_number] => 11124020 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/124020
SNPs of apolipoprotein B and modulation of their expression May 4, 2005 Abandoned
Menu